Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 785 across all filing types
Latest filing 2020-03-13 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
2019 ANNUAL RESULTS OF CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
Regulatory Filings Classification · 95% confidence The document is an announcement by PW Medtech Group Limited regarding the 2019 annual results of China Biologic Products Holdings, Inc. (CBPO), a major associate company. It references the release of CBPO's annual report and earnings release filed with the SEC, and provides a summary of key financial figures from CBPO's audited consolidated financial statements. The document itself is relatively short (4076 characters) and primarily serves to inform shareholders about the associate's annual results and direct them to the full report on the SEC website. It does not contain the full annual report or detailed financial statements of PW Medtech Group Limited itself, nor does it present comprehensive financial data or analysis for PW Medtech. This fits the pattern of a Regulatory Filing (RNS) as it is a regulatory announcement providing summary information and directing to the full report elsewhere, rather than the full Annual Report (10-K) or Earnings Release (ER) itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-03-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 29/02/2020. The content focuses exclusively on share capital changes and securities movements, with no financial performance data, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a share capital change notification. The document is substantive and not a brief announcement or certification. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA).
2020-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/01/2020. The content focuses exclusively on share capital changes and securities movements without any financial performance data, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital or shareholding update. Given the detailed nature of share capital movements and the monthly frequency, this fits best under the category of Share Issue/Capital Change (SHA). The document is not an announcement of a report but the actual monthly return itself, and it is sufficiently long and detailed to be a substantive filing.
2020-02-05 English
VOLUNTARY ANNOUNCEMENT - FIRST AMENDMENT TO THE CONSORTIUM AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding a First Amendment to a Consortium Agreement related to shareholding and a privatization proposal. It references previous announcements and circulars but does not contain financial statements or detailed financial data. The document is relatively short (4028 characters) and serves as an update on a transaction and agreement amendment rather than a full report or detailed financial disclosure. It is not a report publication announcement since it contains substantive information about the amendment itself. The content fits best under Capital/Financing Update (CAP) as it relates to changes in consortium agreements and shareholding arrangements connected to a privatization proposal and disposal of shares.
2020-01-23 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2019
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update or share capital change notice. Given the detailed nature of share capital movements and the monthly frequency, the document fits best under the category 'Share Issue/Capital Change' (SHA). The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement. Therefore, the classification is SHA with high confidence.
2020-01-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions during the month. The content focuses on share capital changes and related confirmations, typical of regulatory filings required by stock exchanges to report monthly share capital movements. It does not contain financial statements, earnings data, or management commentary. It is not an announcement of a report but a detailed regulatory submission about share capital movements. Therefore, the document fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-12-03 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.